News & Updates
The following updates will take place on UnitedHealthcare’s Advantage and Traditional Prescription Drug Lists (PDLs), the the SignatureValue Formulary, and OptumRx direct business on January 1, 2015. If you are unsure of the plan or PDL that applies to your customer, please contact a member of your b&p Sales Team.
Advantage and Traditional PDL Updates
Please note final decisions pending in the Immunomodulator class, please watch for later updates.
Members taking medications impacted by a change will receive a letter in December or earlier. These PDL updates are also communicated to physicians and pharmacies in December.
For more information about the January 1, 2015 pharmacy benefit updates, visit uhc.com/pharmacy.
**Please note not all PDL updates apply to all groups depending on state regulations, riders, and Summary Plan Descriptions (SPDs).
Performance and Classic PDL and SignatureValue Formulary Updates
Effective July 1,2014 for non-HMO legacy PacifiCare and UnitedHealthcare public sector integrated commercial business that has been administered by OptumRx prior to January 1, 2013, Please note these PDL updates impact a small portion of UnitedHealthcare integrated commercial business.
For PacifiCare HMO business administered by OptumRx:
Members taking select medications impacted by a change will receive a letter in June or earlier. These PDL updates are also communicated to physicians and pharmacies in June.
OptumRx Commercial PDL Updates
A recorded presentation of the Core and Select PDL updates will be available in early October.
Members taking select medications impacted by a PDL change will receive a letter 60 days prior to the January 1, 2015 effective date.
For questions, please contact a member of your b&p Sales Team - 888.722.3373.